产品编号 :
Cas No. :
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 询价 | |||
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 | |||
| 250mg | 98% | 询价 | |||
| 1g | 98% | 询价 |
| 包装规格 | 纯度 | 目录价 | 会员专享价 | 库存 | 数量 |
|---|---|---|---|---|---|
| 1mg | 98% | 询价 | |||
| 5mg | 98% | 询价 | |||
| 10mg | 98% | 询价 | |||
| 50mg | 98% | 询价 | |||
| 100mg | 98% | 询价 | |||
| 250mg | 98% | 询价 | |||
| 1g | 98% | 询价 |
CAS No. |
882290-02-0 |
|---|---|
中文名称 |
N'-(3-氯-4-氟苯基)-2-(4-氯苯基)-2-氧代乙烷亚肼基氰化物 |
英文名称 |
N'-(3-Chloro-4-fluorophenyl)-2-(4-chlorophenyl)-2-oxoacetohydrazonoyl cyanide |
别名 |
SC-99;Benzenepropanenitrile, 4-chloro-α-[2-(3-chloro-4-fluorophenyl)hydrazinylidene]-β-oxo-;2-(2-(3-Chloro-4-fluorophenyl)hydrazono)-3-(4-chlorophenyl)-3-oxo-propanenitrile;N'-(3-Chloro-4-fluorophenyl)-2-(4-chlorophenyl)-2-oxoacetohydrazonoyl cyanide;orally,ERK,c-Src,SC 99,ATP-binding,phosphorylation,platelet,AKT,Janus kinase,activation,anti-myeloma,mTOR,anti-thrombotic,Inhibitor,myeloma,pocket,SC99,multiple,aggregation,STAT,OPM2,JAK,SC-99,Apoptosis,inhibit;SC99, 10 mM in DMSO |
标准英文名 |
N-(3-chloro-4-fluorophenyl)-2-(4-chlorophenyl)-2-oxoacetohydrazonoyl cyanide |
MDL No. |
MFCD00176649 |
分子式 |
C15H8Cl2FN3O |
分子量 |
336.15 |
精确分子量 |
335.00 |
SMILES |
N#CC(=NNC1=CC=C(F)C(Cl)=C1)C(=O)C2=CC=C(Cl)C=C2 |
标准SMILES |
N#CC(=NNC1C=C(Cl)C(F)=CC=1)C(=O)C1C=CC(Cl)=CC=1 |
性状 |
Solid |
用途 |
For laboratory research purposes. Not for drug or household use. |
信号词 |
Warning |
InChIKey |
ZKULFSMYRSFHKE-UHFFFAOYSA-N |
危险类别(旧) |
H302,H312,H332 |
存储要求 |
Keep in dark place, Sealed in dry, 2-8°C,Keep container tightly closed in a dry and well-ventilated area. Containers which are opened must be carefully resealed and kept upright to prevent leakage. |
危险品分类 |
Acute toxicity, oral (Category 4),Acute toxicity, dermal (Category 4),Acute toxicity, inhalation (Category 4) |
|---|---|
化学稳定性 |
Stable under recommended storage conditions. |
符号 |
|
|
|
评论 |
|---|